Footnotes
This manuscript has recently been accepted for publication in the ERJ Open Research. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online. Please open or download the PDF to view this article.
Conflict of interest: T.M. Kole has nothing to disclose.
Conflict of interest: S.D. Pouwels has nothing to disclose.
Conflict of interest: R. Bults has nothing to disclose.
Conflict of interest: M.E. Ketelaar has nothing to disclose.
Conflict of interest: V. Guryev has nothing to disclose.
Conflict of interest: L. Koll has nothing to disclose.
Conflict of interest: H.A.M. Kerstjens has nothing to disclose.
Conflict of interest: M.C. Nawijn has nothing to disclose.
Conflict of interest: A. Faiz is a member of TSANZ special interest group.
Conflict of interest: M. van den Berge reports research grants paid to institution by GlaxoSmithKline, Novartis, Astra Zeneca, Roche, Genentech. The submitted work is cofinanced by the Ministry of Economic Affairs and Climate Policy by means of the PPP.
This is a PDF-only article. Please click on the PDF link above to read it.
- Received August 24, 2022.
- Accepted January 9, 2023.
- Copyright ©The authors 2023
This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions{at}ersnet.org
